SCHEMBL4607918

SCHEMBL4607918

COC(=O)Oc1sccc1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.36
HSD17B10 Q99714 4/20 0.36
HPGD P15428 3/20 0.36
MAPT P10636 4/20 0.36
NPC1 O15118 3/20 0.36
ALDH1A1 P00352 6/20 0.35
CFTR P13569 1/20 0.35
PTK2 Q05397 1/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
RAB9A P51151 1/20 0.35
MAPK1 P28482 1/20 0.33
LMNA P02545 2/20 0.33
FLT3 P36888 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4634541 0.82 KMT2A (0.36) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL6609300 0.81 RAB9A (0.37) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL3672729 0.79 KDM4E (0.37) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL10804734 0.79 HPGD (0.41) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL9416574 0.78 HDAC3 (0.39) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL14486887 0.78 MAPT (0.37) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL9533816 0.78 KDM4E (0.36) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL9409748 0.78 CUL4A (0.37) KDM4EHSD17B10HPGDMAPTNPC1
SCHEMBL11335096 0.77 KEAP1 (0.36) KDM4EHSD17B10HPGDMAPTALDH1A1
SCHEMBL3807655 0.76 MEN1 (0.34) HSD17B10MAPTALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1440976-B1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production BOEHRINGER INGELHEIM PHARMA (DE) 2008-07-23 EP disclosed
EP-1664058-B1 SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME SANOFI AVENTIS DEUTSCHLAND (DE) 2007-11-14 EP disclosed
WO-2006072347-A2 ALKINYL-SUBSTITUTED THIOPHENES AICURIS GMBH & CO. KG (DE) 2006-07-13 WO disclosed
EP-1664058-A1 SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME Sanofi-Aventis Deutschland GmbH (DE) 2006-06-07 EP disclosed
EP-1513834-B1 SUBSTITUTED THIOPHENES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR DIAGNOSTIC REAGENT, AND A MEDICAMENT CONTAINING THE SAME SANOFI AVENTIS DEUTSCHLAND (DE) 2006-03-15 EP disclosed
WO-2005026173-A1 SUBSTITUTED THIENOIMIDAZOLES, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT OR DIAGNOSTIC AND MEDICAMENTS COMPRISING THE SAME SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2005-03-24 WO disclosed
EP-1513834-A1 SUBSTITUTED THIOPHENES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR DIAGNOSTIC REAGENT, AND A MEDICAMENT CONTAINING THE SAME Aventis Pharma Deutschland GmbH (DE) 2005-03-16 EP disclosed
EP-1440976-A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production Boehringer Ingelheim Pharma GmbH & Co.KG (DE) 2004-07-28 EP disclosed
EP-0927192-B1 MODIFIED AMINOACIDS, PHARMACEUTICALS CONTAINING THESE COMPOUNDS AND METHOD FOR THEIR PRODUCTION BOEHRINGER INGELHEIM PHARMA (DE) 2004-05-12 EP disclosed
WO-2003101984-A1 SUBSTITUTED THIOPHENES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR DIAGNOSTIC REAGENT, AND A MEDICAMENT CONTAINING THE SAME AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-12-11 WO disclosed
EP-1051888-B1 PROCESS AND SOLUTION FOR THE PRELIMINARY TREATMENT OF COPPER SURFACES ATOTECH DEUTSCHLAND GMBH (DE) 2002-03-27 EP disclosed
EP-1055355-B1 PROCESS FOR THE PRELIMINARY TREATMENT OF COPPER SURFACES ATOTECH DEUTSCHLAND GMBH (DE) 2001-12-05 EP disclosed
EP-1055355-A1 PROCESS FOR THE PRELIMINARY TREATMENT OF COPPER SURFACES ATOTECH Deutschland GmbH (DE) 2000-11-29 EP disclosed
EP-1051888-A1 PROCESS AND SOLUTION FOR THE PRELIMINARY TREATMENT OF COPPER SURFACES ATOTECH Deutschland GmbH (DE) 2000-11-15 EP disclosed
WO-1999040764-A1 PROCESS AND SOLUTION FOR THE PRELIMINARY TREATMENT OF COPPER SURFACES ATOTECH DEUTSCHLAND GMBH (DE) 1999-08-12 WO disclosed
WO-1999040765-A1 PROCESS FOR THE PRELIMINARY TREATMENT OF COPPER SURFACES ATOTECH DEUTSCHLAND GMBH (DE) 1999-08-12 WO disclosed
EP-0378508-B1 Antidotes to modify the resistance of cultivated plants to agrochemical agents CIBA GEIGY AG (CH) 1995-03-01 EP disclosed
EP-0519307-A2 Tetracyclic Imidazodiazepines F. HOFFMANN-LA ROCHE AG (CH) 1992-12-23 EP disclosed
EP-0378508-A2 Antidotes to modify the resistance of cultivated plants to agrochemical agents CIBA-GEIGY AG (CH) 1990-07-18 EP disclosed